Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Helping adults with OCD find and keep employment

Official title: Helping Adults With Obsessive-Compulsive Disorder Succeed at Work

Run by New York State Psychiatric Institute · NCT07124780 · Data updated 2026-11-12

This study will test whether adding Individual Placement and Support (IPS) to standard vocational help helps unemployed adults with OCD who are getting CBT find and maintain competitive work.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment40 (estimated)
SponsorNew York State Psychiatric Institute
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedMay 12, 2026
Main results expectedAugust 2027
Study endsAugust 2027
Registry record updatedJuly 31, 2026
Trial IDNCT07124780 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Unemployed adults living in New York State with a primary diagnosis of OCD who want competitive employment and are not already receiving supported employment services are ideal candidates.

Probably not a fit

People who are already employed, already receiving supported employment, have active suicidality, untreated substance use problems, or comorbid conditions that raise safety risks may not benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial will enroll 40 adults with a primary diagnosis of obsessive-compulsive disorder who are currently unemployed and seeking competitive employment in New York State. All participants receive up to 12 sessions of exposure and response prevention, a form of CBT for OCD, and are then randomly assigned to receive either Individual Placement and Support (IPS) or standard vocational services (SVS). Work and clinical outcomes are measured at baseline, at the end of CBT, and at 6, 9, and 12 months to compare job attainment and job maintenance between groups. The trial is conducted at the New York State Psychiatric Institute and focuses on practical employment outcomes alongside symptom measures.

Why it matters

Potential benefit: If successful, adding IPS could help people with OCD more reliably find and keep competitive jobs when combined with CBT.

How similar studies have gone: IPS has strong evidence for improving employment outcomes in other serious mental illnesses, but applying IPS specifically to OCD is relatively new and has limited prior evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Currently unemployed and interested in finding competitive employment in New York State
* Currently residing in New York State
* Primary diagnosis of OCD
* For those currently on psychiatric medication: On a stable dose of psychiatric medication (for at least 6 weeks) and willing to remain on this dose for the first three months of CBT.
* Access to the internet through a mobile device or computer

Exclusion Criteria:

* In the process of applying for or currently receiving disability benefits
* Currently receiving supported employment services
* Active suicidality or recent suicide attempt
* Active substance use problem (other than nicotine) that warrants treatment
* Comorbid psychiatric conditions that significantly elevate the risk of study participation such as psychotic disorders or bipolar disorder

Where it's running

  • The New York State Psychiatric Institute
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.